Navigation Links
ABR-Affinity BioReagents to Exhibit at ASCB in Washington D.C., December 1 - 5, 2007
Date:11/30/2007

DENVER and GOLDEN, Colo., Nov. 30 /PRNewswire/ -- ABR-Affinity BioReagents, a leading global antibody manufacturer, announced today the company's continued support for the American Society for Cell Biology's 47th Annual Meeting in Washington D.C., December 1 - 5, 2007.

"The ASCB meeting is one of the most significant of the year in terms of contact with our customer base and we feel privileged to participate in this exciting area of research," said Ken Wilczek, President of ABR. "The opportunity to support cell biology research in all of its various facets is of great value to us at ABR. We welcome the chance to participate in discussions with preeminent scientists and researchers who help to shape policy with regard to future direction in this research area," noted Mr. Wilczek.

ABR now offers over 2,500 products for cell biology research, all of which are supported by ABR's 100% Quality Guarantee. "Cell Biology is a key and growing research focus for ABR, with several new and notable products launched in advance of this meeting," noted Mr. Wilczek. Advances in cell biology have been remarkable in recent years, and ABR is at the forefront of this research with a comprehensive line of "off the shelf" and custom antibody products specifically developed to meet and exceed the needs of the life science researcher who focuses on cell biology. ABR-Affinity BioReagents will be located at booth #1154 at The American Society for Cell Biology's 47th Annual Meeting.

About ABR-Affinity BioReagents

Founded in 1989 with world headquarters in Golden, Colorado, ABR-Affinity BioReagents is a world leader in the manufacture and distribution of monoclonal and polyclonal antibodies, kits, recombinant proteins, siRNA, and custom antibody production services, known as Antibody on Demand(R).

With more than 35,000 antibodies focused in 43 research areas, ABR offers a unique value proposition in the life science industry-research antibodies that are 100% quality guaranteed or your money back -- with no questions asked.

Utilizing a distribution network encompassing over 55 nations, ABR products are readily available in every research market on the globe. Products are available directly from ABR in the United States, as well as through an exclusive distribution partnership with Fisher Scientific, a division of Thermo Fisher Scientific.

For additional information about ABR-Affinity BioReagents, contact Leslie Martin with ABR media relations at 1-800-527-4535.


'/>"/>
SOURCE ABR-Affinity BioReagents
Copyright©2007 PR Newswire.
All rights reserved

Related biology technology :

1. ABR-Affinity BioReagents Announces Agreements for U.S. Distribution of Research Antibodies
2. Varian Medical Systems Exhibits Latest Technologies and Products Designed to Improve Speed and Precision of Radiotherapy at ESTRO 2007
3. An Uncommon Eye: Photography Exhibit by Biotechnology Executive at BHCC Gallery
4. MedImmune to Present RSV Surveillance and Cost-Effectiveness Data at American Academy of Pediatrics National Conference & Exhibition
5. Imaging Diagnostic Systems Exhibits CT Laser Breast Imaging Results at Major Italian Multidisciplinary Breast Cancer Meeting
6. Patent on Technology for the Delivery of Stem Cells to the Human Heart Issued to CellCyte Genetics Corp. of Washington
7. Exelixis Announces December 5 Webcast of Its Third Annual R&D Day
8. Reminder: Exelixis Announces December 5 Webcast of Its Third Annual R&D Day
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/18/2017)... ... 18, 2017 , ... Opal Kelly, a leading producer of ... announced the ZEM5310 USB 3.0 FPGA Module, combining a SuperSpeed USB 3.0 interface ... factor suitable for prototyping, testing, and production-ready integration. The ZEM5310 USB interface delivers ...
(Date:1/18/2017)... 18, 2017   Boston Biomedical , an industry ... target cancer stemness pathways, will feature data from two ... the 2017 ASCO Gastrointestinal Cancers Symposium, held from January ... Napabucasin is an orally-administered investigational agent designed ... Cancer stem cells (CSCs) possess the property of ...
(Date:1/18/2017)...   Parent Project Muscular Dystrophy (PPMD) , a ... muscular dystrophy (Duchenne) , today announced a $600,000 grant ... Technology (NJIT) and Talem Technologies (Talem) as part of ... to assist people living with Duchenne. PPMD is funding ... embedded computer, software, a force sensor and a motor ...
(Date:1/18/2017)... ... 18, 2017 , ... Total Orthopedics and Sports Medicine ( ... The operation took place on Wednesday, January 11, 2017 at Long Island Jewish, ... cervical discectomy and fusion on a 42 year old female who was in ...
Breaking Biology Technology:
(Date:1/6/2017)... 2017  Privately-held CalciMedica, Inc., announced that it ... of a novel calcium release-activated calcium (CRAC) channel ... Acute pancreatitis, sudden painful inflammation of ... can be very serious.  In severe cases it can ... hospital stays, time in the ICU and substantial ...
(Date:1/3/2017)... -- Onitor, provider of digital health technology for consumers, ... biometric data-driven program designed to aid weight loss for ... Consumer Electronics Show (CES) in Las Vegas ... World Health Organization (WHO), have identified lifestyle risks that ... overweight or obese. WHO also states that more people ...
(Date:12/19/2016)... BARCELONA , España y TORONTO , 19 ... fusión con Northern Biologics Inc. que permitirá el desarrollo acelerado de ... ensayos clínicos en varios tipos de tumor en 2017, con múltiples ... ... de su clase con objetivo en el factor inhibidor de leucemia ...
Breaking Biology News(10 mins):